Scientific Founder and Advisory Board Member
Dr. Matthew Porteus
Dr. Matthew Porteus is an Associate Professor of Pediatrics, Department of Pediatrics, Divisions of Hematology/Oncology and Human Gene Therapy, at Stanford School of Medicine. His research focuses on developing homologous recombination-based therapies for genetic and other diseases. He has a clinical practice at the Lucille Packard Children’s Hospital, where he is an Attending Physician for the Pediatric Bone Marrow Transplant Service. Matthew graduated Magna Cum Laude from Harvard University and completed his M.D. and Ph.D. degrees at Stanford. He did his residency training in pediatrics at Boston Children’s Hospital, and fellowship training in Pediatric Hematology/Oncology at Boston Children’s Hospital and the Dana Farber Cancer Institute. For his post-doctoral work, Matthew trained with Dr. David Baltimore at the Massachusetts Institute of Technology and the California Institute of Technology. During this time he began studying gene editing and was the first to show that engineered nucleases could be used to precisely modify human cells by homologous recombination.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.